Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical cancer immunotherapy: Current progress and prospects. | Front Immunol | 2022 | 36304470 | PubTator, text mining | PubMed |
| Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. | Heliyon | 2022 | 36299526 | PubTator, text mining | PubMed |
| Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis. | Viruses | 2022 | 36298660 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis. | J Clin Med | 2022 | 36294458 | PubTator, text mining | PubMed |
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring. | Cancers (Basel) | 2022 | 36291936 | PubTator, text mining | PubMed |
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools. | Curr Oncol | 2022 | 36290820 | PubTator, text mining | PubMed |
| Opposite Effect of Thyroid Hormones on Oxidative Stress and on Mitochondrial Respiration in COVID-19 Patients. | Antioxidants (Basel) | 2022 | 36290721 | PubTator, text mining | PubMed |
| NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells. | Biomedicines | 2022 | 36289712 | PubTator, text mining | PubMed |
| Adapter CAR T Cell Therapy for the Treatment of B-Lineage Lymphomas. | Biomedicines | 2022 | 36289682 | PubTator, text mining | PubMed |
| A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas. | J Clin Invest | 2022 | 36282572 | PubTator, text mining | PubMed |
| Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma. | Biomed Res Int | 2022 | 36281462 | PubTator, text mining | PubMed |
| Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy. | BMC Med | 2022 | 36280874 | PubTator, text mining | PubMed |
| Identification and molecular analysis of RNF31 Q622H germline polymorphism. | Oncol Lett | 2022 | 36276481 | PubTator, text mining | PubMed |
| Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma. | Front Immunol | 2022 | 36275646 | PubTator, text mining | PubMed |
| Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting influenza susceptibility. | Front Microbiol | 2022 | 36274727 | PubTator, text mining | PubMed |
| Cryomicroscopy reveals the structural basis for a flexible hinge motion in the immunoglobulin M pentamer. | Nat Commun | 2022 | 36274064 | PubTator, text mining | PubMed |
| The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings? | Radiat Oncol | 2022 | 36273167 | PubTator, text mining | PubMed |
| Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling. | Cell Discov | 2022 | 36270988 | PubTator, text mining | PubMed |
| Combining precision oncology and immunotherapy by targeting the MALT1 protease. | J Immunother Cancer | 2022 | 36270731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=53